Cellosaurus SW756 (CVCL_1727)

Cell line name SW756
Synonyms SW-756; SW 756
Accession CVCL_1727
Resource Identification Initiative To cite this cell line use: SW756 (RRID:CVCL_1727)
Comments From: Scott and White Clinic; Temple; Texas; USA.
Characteristics: Contains a complete HPV18 genome.
Microsatellite instability: Stable (MSS) (Sanger).
Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Human papillomavirus-related cervical squamous cell carcinoma (NCIt: C27676)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): ATCC; Cosmic-CLP

Markers:
AmelogeninX
CSF1PO11,12
D13S31711
D16S53912,13
D5S81811,12
D7S82010,12
TH019.3
TPOX8
vWA17
Publications

PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

PubMed=6935474; DOI=10.1093/jnci/66.2.239
Wright W.C., Daniels W.P., Fogh J.
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
J. Natl. Cancer Inst. 66:239-247(1981)

PubMed=7129487; DOI=10.1007/BF02796428
Freedman R.S., Bowen J.M., Leibovitz A., Pathak S., Siciliano M.J., Gallager H.S., Giovanella B.C.
Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix.
In Vitro 18:719-726(1982)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3029760; DOI=10.1073/pnas.84.4.1070
Durst M., Croce C.M., Gissmann L., Schwarz E., Huebner K.
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.
Proc. Natl. Acad. Sci. U.S.A. 84:1070-1074(1987)

PubMed=15531914; DOI=10.1038/sj.onc.1208235
Baldus S.E., Schwarz E., Lohrey C., Zapatka M., Landsberg S., Hahn S.A., Schmidt D., Dienes H.-P., Schmiegel W.H., Schwarte-Waldhoff I.
Smad4 deficiency in cervical carcinoma cells.
Oncogene 24:810-819(2005)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections ATCC; CRL-10302
Cell line databases/resources Cosmic-CLP; 724839
GDSC; 724839
IGRhCellID; SW756
IGRhCellID; SW756GEO
LINCS_LDP; LCL-1544
Ontologies CLO; CLO_0009223
EFO; EFO_0002370
Biological sample resources BioSample; SAMN03471299
Chemistry resources ChEMBL-Cells; CHEMBL3308790
ChEMBL-Targets; CHEMBL1075594
Gene expression databases GEO; GSM113867
GEO; GSM253303
GEO; GSM675739
GEO; GSM685443
GEO; GSM1670511
Polymorphism and mutation databases Cosmic; 724839
Cosmic; 925359
Cosmic; 1131522
Cosmic; 1193032